Skip to main content
Livermore
Livermore
ZHEN

Stanley-Laman Group, Ltd.

SEC CIK
0001601489
Latest filing
Aug 5, 2026

The latest 13F from Stanley-Laman Group, Ltd. covers Q2 2026 (filed Aug 5, 2026): 298 long positions worth $984.2M. The top 10 holdings make up 20.4% of the portfolio, and the largest is Lam Research Corp (LRCX) at 2.8%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
33
Est. +$64.5M
Added
59
Est. +$13.9M
Reduced
120
Est. −$54.0M
Sold out
29
Est. −$37.2M

Top 5 holdings

Share of this quarter's portfolio value

  1. LRCXLam Research Corp
    2.8%$27.6MHistory
  2. GOOGLAlphabet Inc.
    2.7%$26.7MHistory
  3. KLACKLA Corp
    2.3%$22.8MHistory
  4. AMDAdvanced Micro Devices Inc
    2.3%$22.2MHistory
  5. AMZNAmazon Com Inc
    1.9%$18.5MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. TERTeradyne, Inc
    +$9.75MNewHistory
  2. STXSeagate Technology Holdings plc
    +$8.46MNewHistory
  3. FNFabrinet
    +$6.28MNewHistory
  4. BDCBelden Inc.
    +$4.25MNewHistory
  5. RRXRegal Rexnord Corp
    +$4.07MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. TERTeradyne, Inc
    +0.99 pp0.0% → 1.0%History
  2. STXSeagate Technology Holdings plc
    +0.86 pp0.0% → 0.9%History
  3. FNFabrinet
    +0.64 pp0.0% → 0.6%History
  4. BDCBelden Inc.
    +0.43 pp0.0% → 0.4%History
  5. RRXRegal Rexnord Corp
    +0.41 pp0.0% → 0.4%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ASMLASML Holding NV
    −$9.16MReducedHistory
  2. METAMeta Platforms, Inc.
    −$7.21MReducedHistory
  3. ADIAnalog Devices Inc
    −$6.01MSold outHistory
  4. ISRGIntuitive Surgical Inc
    −$5.74MReducedHistory
  5. PTCPTC Inc.
    −$3.86MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. METAMeta Platforms, Inc.
    −0.91 pp1.0% → 0.1%History
  2. ISRGIntuitive Surgical Inc
    −0.87 pp1.0% → 0.1%History
  3. ADIAnalog Devices Inc
    −0.74 pp0.7% → 0.0%History
  4. VALValaris Ltd
    −0.50 pp1.3% → 0.8%History
  5. PTCPTC Inc.
    −0.48 pp0.5% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$984.2M
+$172.5M (+21.2%) vs. prior quarter
Positions
298
+4 vs. prior quarter
Top 10 concentration
20.4%
Top 10 as share of value
Turnover
8.7%
Q2 2026, one quarter
Average holding period
10.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $984.2M (Q2 2026)

Q1 2021: $605.9MQ2 2021: $703.5MQ3 2021: $768.7MQ4 2021: $849.8MQ1 2022: $722.2MQ2 2022: $562.1MQ3 2022: $527.2MQ4 2022: $524.8MQ1 2023: $561.7MQ2 2023: $605.5MQ3 2023: $586.0MQ4 2023: $653.6MQ1 2024: $713.2MQ2 2024: $695.9MQ3 2024: $712.3MQ4 2024: $712.1MQ1 2025: $649.9MQ2 2025: $673.3MQ3 2025: $699.3MQ4 2025: $784.7MQ1 2026: $811.8MQ2 2026: $984.2M
Q1 2021Q2 2026
13F filings of Stanley-Laman Group, Ltd. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 5, 2026298$984.2MLRCXGOOGLKLACvs. Q1 2026SEC
Q1 2026Apr 16, 2026294$811.8MGOOGLAMZNRTXvs. Q4 2025SEC
Q4 2025Jan 23, 2026305$784.7MGOOGLMSFTAMZNvs. Q3 2025SEC
Q3 2025Oct 22, 2025251$699.3MMSFTGOOGLAMZNvs. Q2 2025SEC
Q2 2025Jul 29, 2025283$673.3MMSFTCCJRTXvs. Q1 2025SEC
Q1 2025Apr 16, 2025282$649.9MMSFTOKTALINvs. Q4 2024SEC
Q4 2024Jan 29, 2025282$712.1MVanguard S&P 500 ETFGRSDMSFTvs. Q3 2024SEC
Q3 2024Oct 22, 2024291$712.3MMSFTGRSDCCJvs. Q2 2024SEC
Q2 2024Jul 18, 2024271$695.9MMSFTPODDCCJvs. Q1 2024SEC
Q1 2024Apr 17, 2024248$713.2MMSFTCXMPODDvs. Q4 2023SEC
Q4 2023Feb 2, 2024233$653.6MMSFTGRSDCXMvs. Q3 2023SEC
Q3 2023Oct 16, 2023232$586.0MGRSDMSFTCCJvs. Q2 2023SEC
Q2 2023Aug 8, 2023235$605.5MSDGRMSFTGTLBvs. Q1 2023SEC
Q1 2023Apr 18, 2023224$561.7MGRSDMSFTLINvs. Q4 2022SEC
Q4 2022Jan 19, 2023219$524.8MMSFTLINRTXvs. Q3 2022SEC
Q3 2022Oct 18, 2022230$527.2MPINSFROGHOODvs. Q2 2022SEC
Q2 2022Aug 8, 2022267$562.1MMSFTPINSGTLBvs. Q1 2022SEC
Q1 2022Apr 21, 2022270$722.2MSNAPHOODMSFTvs. Q4 2021SEC
Q4 2021Jan 25, 2022258$849.8MGOOGLMSFTADBEvs. Q3 2021SEC
Q3 2021Nov 3, 2021253$768.7MNVDAGOOGLPYPLvs. Q2 2021SEC
Q2 2021Jul 28, 2021246$703.5MNVDAPYPLADBEvs. Q1 2021SEC
Q1 2021May 5, 2021240$605.9MPYPLNVDAADBE–SEC